Nicholas Investment Partners, LP Novo Cure LTD Transaction History

Nicholas Investment Partners, LP

$912 Million
Q4 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$75.08 - $121.99 $5.15 Million - $8.37 Million	-68,593 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $1.91 Million - $3.2 Million	-16,434 Reduced 19.33%	68,593 $7.97 Million
Q2 2021 Aug 10, 2021	SELL	$130.4 - $225.58 $9.92 Million - $17.2 Million	-76,110 Reduced 47.23%	85,027 $18.9 Million
Q1 2021 May 14, 2021	BUY	$124.11 - $190.17 $3.2 Million - $4.91 Million	25,801 Added 19.06%	161,137 $21.3 Million
Q4 2020 Feb 11, 2021	SELL	$112.16 - $174.14 $7.21 Million - $11.2 Million	-64,277 Reduced 32.2%	135,336 $23.4 Million
Q3 2020 Nov 13, 2020	BUY	$58.05 - $111.31 $9.22 Million - $17.7 Million	158,817 Added 389.3%	199,613 $22.2 Million
Q2 2020 Aug 12, 2020	SELL	$57.2 - $74.41 $3.39 Million - $4.42 Million	-59,339 Reduced 59.26%	40,796 $2.42 Million
Q1 2020 May 13, 2020	BUY	$57.05 - $95.75 $815,815 - $1.37 Million	14,300 Added 16.66%	100,135 $6.74 Million
Q4 2019 Feb 13, 2020	SELL	$68.3 - $93.8 $5.05 Million - $6.93 Million	-73,879 Reduced 46.26%	85,835 $7.23 Million
Q3 2019 Nov 13, 2019	BUY	$61.86 - $97.8 $841,790 - $1.33 Million	13,608 Added 9.31%	159,714 $11.9 Million
Q2 2019 Aug 09, 2019	SELL	$42.22 - $63.23 $1.11 Million - $1.66 Million	-26,211 Reduced 15.21%	146,106 $9.24 Million
Q1 2019 May 15, 2019	SELL	$31.96 - $56.12 $108,152 - $189,910	-3,384 Reduced 1.93%	172,317 $8.3 Million
Q4 2018 Feb 14, 2019	SELL	$28.72 - $52.63 $26,623 - $48,788	-927 Reduced 0.52%	175,701 $5.88 Million
Q3 2018 Nov 14, 2018	BUY	$32.0 - $52.4 $3.9 Million - $6.39 Million	121,875 Added 222.59%	176,628 $9.26 Million
Q2 2018 Aug 14, 2018	BUY	$19.85 - $32.0 $1.09 Million - $1.75 Million	54,753 New	54,753 $1.71 Million

Others Institutions Holding NVCR

# of Institutions

290

Shares Held

75.6M

Call Options Held

1.77M

Put Options Held

538K

Black Rock Inc. New York, NY

12.1M
Shares

$246 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$239 Million
0.01% of portfolio
Capital International Investors Los Angeles, CA

8.87M
Shares

$180 Million
0.05% of portfolio
Capital World Investors Los Angeles, CA

4.82M
Shares

$97.7 Million
0.02% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

2.74M
Shares

$55.6 Million
5.68% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.13B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Account